Illumina Showcases Latest Advancements in Genomic Testing for Oncology at ASCO 2024
Illumina, a leading name in DNA sequencing and array-based technologies, presented its latest research findings at the American Society of Clinical Oncology (ASCO) Annual Meeting held from May 31st to June 4th, 2024, in Chicago. The presentations highlighted the company’s commitment to advancing genomic testing in cancer care through collaborations and ongoing research initiatives. Focus […]
Illumina Showcases Latest Advancements in Genomic Testing for Oncology at ASCO 2024 Read More »